{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:49Z","timestamp":1792784209548,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"France-Alzheimer association"},{"name":"CNRS"},{"name":"Regional Council of Martinique"},{"name":"National Foundation for Alzheimer's Disease and Related Disorders"},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01-AG020197"],"award-info":[{"award-number":["R01-AG020197"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007013","name":"Hoffmann-La Roche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.neurobiolaging.2013.05.013","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T03:02:44Z","timestamp":1371870164000},"page":"2613-2622","source":"Crossref","is-referenced-by-count":35,"title":["Amyloid beta immunization worsens iron deposits in the choroid plexus and cerebral microbleeds"],"prefix":"10.1016","volume":"34","author":[{"given":"Nelly","family":"Joseph-Mathurin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ol\u00e8ne","family":"Dorieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie G.","family":"Trouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allal","family":"Boutajangout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Kraska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Font\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Verdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar M.","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Mestre-Franc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Dhenain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12603-013-0001-3","article-title":"Editorial: passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed?","volume":"17","author":"Aisen","year":"2013","journal-title":"J.\u00a0Nutr. Health Aging"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib2","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/j.1460-9568.2006.05149.x","article-title":"Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages","volume":"24","author":"Asuni","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF03401708","article-title":"Characterisation of new polyclonal specific for 40 and 42 amino acid-long amyloid \u00df peptides: their use to examine the cell biology of presenilins and the immunochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases","volume":"3","author":"Barelli","year":"1997","journal-title":"Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib4","doi-asserted-by":"crossref","first-page":"e56593","DOI":"10.1371\/journal.pone.0056593","article-title":"Micro-MRI study of cerebral aging: detection of hippocampal subfield reorganization, microhemorrhages, and amyloid plaques in mouse lemur primates","volume":"8","author":"Bertrand","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-010-0705-y","article-title":"Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease","volume":"120","author":"Boche","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0197-4580(94)90115-5","article-title":"Identification of amyloid beta protein in the brain of the small, short-lived lemurian primate Microcebus murinus","volume":"15","author":"Bons","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(97)00458-9","article-title":"A\u00a0stereotaxic atlas of the grey lesser mouse lemur brain (Microcebus murinus)","volume":"46","author":"Bons","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/intimm\/dxg049","article-title":"Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid","volume":"15","author":"Cribbs","year":"2003","journal-title":"Intern. Immunol."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1471-4159.2003.02221.x","article-title":"Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain","volume":"88","author":"Deane","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib10","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mrm.10612","article-title":"Regional atrophy in the brain of lissencephalic mouse lemur primates: measurement by automatic histogram-based segmentation of MR images","volume":"50","author":"Dhenain","year":"2003","journal-title":"Magn. Res. Med."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","article-title":"Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease","volume":"14","author":"Ferrer","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00002093-200401000-00009","article-title":"Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta)","volume":"18","author":"Gandy","year":"2004","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib14","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.vaccine.2005.11.039","article-title":"Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch","volume":"24","author":"Ghochikyan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib15","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease","volume":"38","author":"Hock","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib19","first-page":"181","article-title":"The antigenic index: a novel algorithm for predicting antigenic determinants","volume":"4","author":"Jameson","year":"1988","journal-title":"Comput. Appl. Biosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"A\u00a0beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib21","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.55.9.1340","article-title":"MR choroid plexus sign of iron overload","volume":"55","author":"Kira","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.neurobiolaging.2009.05.018","article-title":"Age associated cerebral atrophy in mouse lemur primates","volume":"32","author":"Kraska","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.arr.2011.07.001","article-title":"The grey mouse lemur: a non-human primate model for ageing studies","volume":"11","author":"Languille","year":"2012","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0002-9440(10)63296-8","article-title":"Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet","volume":"165","author":"Lemere","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0969-9961(03)00044-5","article-title":"Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice","volume":"14","author":"Lemere","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib26","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1096\/fj.06-6463fje","article-title":"Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models","volume":"20","author":"Levites","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib27","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1523\/JNEUROSCI.0381-06.2006","article-title":"Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response","volume":"26","author":"Maier","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer's disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib29","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1210\/en.2008-1610","article-title":"Altered iron metabolism is part of the choroid plexus response to peripheral inflammation","volume":"150","author":"Marques","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2202-10-135","article-title":"The choroid plexus response to a repeated peripheral inflammatory stimulus","volume":"10","author":"Marques","year":"2009","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000148590.39911.DF","article-title":"Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease","volume":"64","author":"Masliah","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fncel.2012.00025","article-title":"Modulation of iron metabolism in aging and in Alzheimer's disease: relevance of the choroid plexus","volume":"6","author":"Mesquita","year":"2012","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/nbdi.1999.0270","article-title":"Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta 1-42 and beta 1-40 immunoreactivity profiles","volume":"7","author":"Mestre-Frances","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib34","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/j.jalz.2010.05.720","article-title":"Abeta derivative vaccination in old mouse lemur primates","volume":"6","author":"Mestre-Frances","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","article-title":"A\u00a0beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease","volume":"408","author":"Morgan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib36","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1073\/pnas.0703137104","article-title":"Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice","volume":"104","author":"Muhs","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-5-42","article-title":"Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice","volume":"5","author":"Petrushina","year":"2008","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib40","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","article-title":"Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta","volume":"25","author":"Racke","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib43","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1523\/JNEUROSCI.2377-07.2008","article-title":"Immunotherapy reduces vascular amyloid-beta in PDAPP mice","volume":"28","author":"Schroeter","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib44","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/brain\/awq056","article-title":"Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology","volume":"133","author":"Serrano-Pozo","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib45","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1523\/JNEUROSCI.1344-04.2004","article-title":"An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives","volume":"24","author":"Sigurdsson","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9440(10)61715-4","article-title":"Immunization with a nontoxic\/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice","volume":"159","author":"Sigurdsson","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations\u00a0from the Alzheimer's Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib48","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1073\/pnas.0813404106","article-title":"Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated microhemorrhages in aged Tg2576 mice","volume":"106","author":"Thakker","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib49","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.vaccine.2008.12.012","article-title":"Antibody response and plasma Abeta1-40 levels in young Microcebus murinus primates immunized with Abeta1-42 and its derivatives","volume":"27","author":"Trouche","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5414\/NPP29209","article-title":"Cerebral amyloid angiopathy and microhemorrhages after amyloid beta vaccination: case report and brief review","volume":"29","author":"Uro-Coste","year":"2010","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib51","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1523\/JNEUROSCI.5077-10.2011","article-title":"Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy","volume":"31","author":"Wang","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib52","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1523\/JNEUROSCI.0293-11.2011","article-title":"The second-generation active Abeta immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects","volume":"31","author":"Wiessner","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib53","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuroscience.2006.10.020","article-title":"Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid","volume":"144","author":"Wilcock","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2013.05.013_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-1-24","article-title":"Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage","volume":"1","author":"Wilcock","year":"2004","journal-title":"J.\u00a0Neuroinflammation"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013002236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458013002236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T13:13:41Z","timestamp":1588943621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458013002236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0197458013002236"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.05.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718027224.793479814","asserted-by":"object"}]},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}